17 November 2020>: Original Paper
Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings
Marcos Vinicius de Sousa 1ABCDEF* , Ana Claudia Gonçalez 2CD , Ricardo de Lima Zollner 3DE , Marilda Mazzali 1ADEDOI: 10.12659/AOT.925488
Ann Transplant 2020; 25:e925488
Figure 1 Dynamics of mean fluorescence intensity (MFI) of donor-specific anti-HLA antibodies (DSA) after the treatment of antibody-mediated rejection (AMR) with intravenous immunoglobulin (IVIG) and/or plasmapheresis (PP).